These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25625022)

  • 1. The sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolism.
    Cox BL; Mackie TR; Eliceiri KW
    Am J Nucl Med Mol Imaging; 2015; 5(1):1-13. PubMed ID: 25625022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
    Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
    J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
    Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
    Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
    Dimitrakopoulou-Strauss A; Strauss L
    Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.
    Dearling JL; Flynn AA; Sutcliffe-Goulden J; Petrie IA; Boden R; Green AJ; Boxer GM; Begent RH; Pedley RB
    J Nucl Med; 2004 Jan; 45(1):101-7. PubMed ID: 14734681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
    Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
    Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron emission tomography imaging of brain tumors.
    Wong TZ; van der Westhuizen GJ; Coleman RE
    Neuroimaging Clin N Am; 2002 Nov; 12(4):615-26. PubMed ID: 12687915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SU-D-217A-04: Evaluation of the Spatial Concordance Between the Intratumoral Patterns of 18F-FLT and 18F-FDG Uptake in a Small Animal Tumor Model.
    Bass C; Axente M; He J; Sundaresan G; Hirsch J; Hugo G; Zweit J; Pugachev A
    Med Phys; 2012 Jun; 39(6Part3):3621. PubMed ID: 28517418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
    Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
    J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Evolving Role of Succinate in Tumor Metabolism: An
    Garrigue P; Bodin-Hullin A; Balasse L; Fernandez S; Essamet W; Dignat-George F; Pacak K; Guillet B; Taïeb D
    J Nucl Med; 2017 Nov; 58(11):1749-1755. PubMed ID: 28619735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    Tseng JC; Narayanan N; Ho G; Groves K; Delaney J; Bao B; Zhang J; Morin J; Kossodo S; Rajopadhye M; Peterson JD
    PLoS One; 2017; 12(8):e0182689. PubMed ID: 28792505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
    Cullinane C; Dorow DS; Jackson S; Solomon B; Bogatyreva E; Binns D; Young R; Arango ME; Christensen JG; McArthur GA; Hicks RJ
    J Nucl Med; 2011 Aug; 52(8):1261-7. PubMed ID: 21764800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of FDG-PET imaging in understanding tumor-host interaction.
    Gatenby RA
    J Nucl Med; 1995 May; 36(5):893-9. PubMed ID: 7738670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of animal handling on the results of 18F-FDG PET studies in mice.
    Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
    J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.
    Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H
    J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.